Prader-Willi syndrome: Who can have growth hormone?

Archives of Disease in Childhood

Volumn 93, Issue 4, 2008, Pages 341-345

  Stafler, P ^a   Wallis, C ^b  

^a Paediatric Intensive Care Unit   (United Kingdom)

^b Respiratory Unit   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; HUMAN GROWTH HORMONE;

ARTIFICIAL VENTILATION; BASAL METABOLIC RATE; DEATH; DIET SUPPLEMENTATION; ENT EXAMINATION; GAS EXCHANGE; HORMONAL THERAPY; HYDRATION; MORTALITY; OBESITY; OXIMETRY; OXYGEN CONSUMPTION; POLYSOMNOGRAPHY; PRADER WILLI SYNDROME; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SLEEP; SLEEP DISORDERED BREATHING; SUDDEN DEATH; UPPER RESPIRATORY TRACT OBSTRUCTION; BREATHING DISORDER; CHEMICALLY INDUCED DISORDER; CHILD; DRUG MONITORING; HUMAN; METHODOLOGY; MONITORING; PATIENT SELECTION; SLEEP APNEA SYNDROME;

CHILD; DRUG MONITORING; HUMAN GROWTH HORMONE; HUMANS; MONITORING, PHYSIOLOGIC; PATIENT SELECTION; POLYSOMNOGRAPHY; PRADER-WILLI SYNDROME; RESPIRATION DISORDERS; RISK FACTORS; SLEEP APNEA SYNDROMES;

EID: 42249094576     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.2007.126334     Document Type: Review

References (38)

1. Myers SE, Carrel AL, Whitman BY, et al. Sustained benefit after 2 years of growth hormone on body composition, fat utilization, physical strength and agility, and growth in Prader-Willi syndrome. J Pediatr 2000;137:42-9.
2. Lindgren AC, Ritzen EM. Five years of growth hormone treatment in children with Prader-Willi syndrome. Acta Paediatr 1999;88(433 Suppl):109-11.
3. Eiholzer U, Nordmann Y, L'Allemand D, et al. Improving body composition and physical activity in Prader-Willi Syndrome, J Pediatr 2003;142:73-8.
4. Paterson WF, Donaldson MD. Growth hormone therapy in the Prader-Willi syndrome. Arch Dis Child 2003;88:283-5.
5. Schrander-Stumpel C, Sijstermans H, Curfs L, et al. Sudden death in children with Prader-Willy syndrome: a call for collaboration. Genet Couns 1998;9:231-2.
6. Oiglane E, Ounap K, Bartsch O, et al. Sudden death of a girl with Prader-Willi syndrome. Genet Couns 2002;13:459-64.
7. Nordmann Y, Eiholzer U, L'Allemand D, et al. Sudden death of an infant with Prader-Willi syndrome-not a unique case? Biol Neonate 2002;82:139-41.
8. Eiholzer U, Nordmann Y, L'Allemand D. Fatal outcome of sleep apnoea in PWS during the initial phase of growth hormone treatment. Acase report. Horm Res 2002;58(Suppl 3):24-6.
9. Vliet GV, Deal CL, Crock PA, et al. Sudden death in growth hormone-treated children with Prader-Willi syndrome. J Pediatr 2004;144:129-31.
10. Eiholzer U. Deaths in children with prader-willi syndrome. Horm Res 2005;63:33-9.
11. Sacco M, Di Giorgio G. Sudden death in Prader-Willi syndrome during growth hormone therapy. Horm Res 2005,63:29-32.
12. Nagai T, Obata K, Tonoki H, et al. Cause of sudden, unexpected death of Prader-Willi syndrome patients with or without growth hormone treatment. Am J Med Genet A 2005;136:45-8.
13. Riedl S, Blumel P, Zwiauer K, et al. Death in two female Prader-Willi syndrome patients during the early phase of growth hormone treatment. Acta Paediatr 2005;94:974-7.
14. Grugni G, Livieri C, Corrias A, et al. Death during GH therapy in children with Prader-Willi syndrome: description of two new cases. J Endocrinol Invest 2005;28:554-7.
15. Craig ME, Cowell CT, Larsson P, et al. Growth hormone treatment and adverse events in Prader-Willi syndrome: data from KIGS (the Pfizer International Growth Database). Clin Endocrinol 2006;65:178-85.
16. Nolte W, Radisch C, Rodenbeck A, et al. Polysomnographic findings in five adult patients with pituitary insufficiency before and after cessation of human growth hormone replacement therapy. Clin Endocrinol 2002;56:805-10.
17. Gerard JM, Garibaldi L, Myers SE, et al. Sleep apnea in patients receiving growth hormone. Clin Pediatr 1997;36:321-6.
18. Haqq AM, Stadler DD, Jackson RH, et al. Effects of growth hormone on pulmonary function, sleep quality, behavior, cognition, growth velocity, body composition, and resting energy expenditure in Prader-Willi syndrome. J Clin Endocrinol Metab 2003;88:2206-12.
19. Wilson SS, Cotterill AM, Harris MA. Growth hormone and respiratory compromise in Prader-Willi Syndrome. Arch Dis Child 2006;91:349- 50.
20. Menendez AA. Abnormal ventilatory responses in patients with Prader-Willi syndrome. Eur J Pediatr 1999;158:941-2.
21. Arens R, Gozal D, Omlin KJ, et al. Hypoxic and hypercapnic ventilatory responses in Prader-Willi syndrome. J Appl Physiol 1994;77:2224-30.
22. Gozal D, Arens R, Omlin KJ, et al. Absent peripheral chemosensitivity in Prader-Willi syndrome. J Appl Physiol 1994;77:2231-6.
23. Orenstein DM, Boat TF, Owens RP, et al. The obesity hypoventilation syndrome in children with the Prader-Willi syndrome: a possible role for familial decreased response to carbon dioxide. J Pediatr 1980;97:765-7.
24. Schluter B, Buschatz D, Trowitzsch E, et al. Respiratory control in children with Prader-Willi syndrome. Eur J Pediatr 1997;156:65-8.
25. Priano L, Grugni G, Miscio G, et al. Sleep cycling alternating pattern (CAP) expression is associated with hypersomnia and GH secretory pattern in Prader-Willi syndrome. Sleep Med 2006;7:627-33.
26. Hertz G, Cataletto M, Feinsilver SH, et al. Sleep and breathing patterns in patients with Prader Willi syndrome (PWS): effects of age and gender. Sleep 1993;16:366-71.
27. O'Donoghue FJ, Camfferman D, Kennedy JD, et al. Sleep-disordered breathing in Prader-Willi syndrome and its association with neurobehavioral abnormalities. J Pediatr 2005;147:823-9.
28. Lin HY, Lin SP, Lin CC, et al. Polysomnographic characteristics in patients with Prader-Willi syndrome. Pediatr Pulmonol 2007;42:881-7.
29. Schrander-Stumpel CT, Curfs LM, Sastrowijoto P, et al. Prader-Willi syndrome: causes of death in an international series of 27 cases. Am J Med Genet A 2004;124:333-8.
30. Festen DAM, de Weerd AW, van den Bossche RAS, et al. Steep-related breathing disorders in prepubertal children with Prader-Willi syndrome and effects of growth hormone treatment. J Clin Endocrinol Metab 2006;91:4911-5.
31. Whitman BY, Myers S, Carrel A, et al. The behavioral impact of growth hormone treatment for children and adolescents with Prader-Willi syndrome: a 2-year, controlled study. Pediatrics 2002;109:E35.
32. Lindgren AC, Hellstrom LG, Ritzen EM, et al. Growth hormone treatment increases CO(2) response, ventilation and central inspiratory drive in children with Prader-Willi syndrome. Eur J Pediatr 1999;158:936-40.
33. Van Vliet G, Deal CL, Crock PA, et al. Sudden death in growth hormone-treated children with Prader-Willi syndrome. J Pediatr 2004;144:129-31.
34. Cadieux RJ, Kales A, Santen RJ, et al. Endoscopic findings in sleep apnea associated with acromegaly. J Clin Endocrinol Metab 1982;55:18-22.
35. Arens R, Gozal D, Burrell BC, et al. Arousal and cardiorespiratory responses to hypoxia in Prader-Willi syndrome. Am J Respir Crit Care Med 1996;153:283-7.
36. Moller J, Nielsen S, Hansen TK. Growth hormone and fluid retention. Horm Res 1999;51(Suppl 3):116-20.
37. Clarke DJ, Waters J, Corbett JA. Adults with Prader-Willi syndrome: abnormalities of sleep and behaviour. J R Soc Med 1989;82:21-4.
38. Chervin RD, Hedger K, Dillon JE, et al. Pediatric sleep questionnaire (PSQ): validity and reliability of scales for sleep-disordered breathing, snoring, sleepiness, and behavioral problems. Sleep Med 2000;1:21-32.